Statistics

Total Visits

Views
Eribulin-trastuzumab combination in HER2-positive metastatic breast cancer: updated results from a Russian observational study 121

Total Visits Per Month

November 2025 December 2025 January 2026 February 2026 March 2026 April 2026 May 2026
Eribulin-trastuzumab combination in HER2-positive metastatic breast cancer: updated results from a Russian observational study 1 0 1 5 6 8 4

File Visits

Views
SCOPUS2079701X-2021-20-SID85123097278-a1.pdf 6

Top country views

Views
Russia 35

Top cities views

Views
Kazan 35

Search DSpace


Advanced Search

Browse

My Account

Statistics